| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.44B | 3.49B | 3.57B | 3.32B | 2.55B | 2.26B |
| Gross Profit | 780.00M | 848.00M | 857.40M | 763.40M | 583.50M | 550.10M |
| EBITDA | 416.40M | 472.00M | 507.30M | 477.80M | 463.20M | 342.20M |
| Net Income | 47.40M | 142.00M | 164.60M | 155.70M | 243.10M | 24.80M |
Balance Sheet | ||||||
| Total Assets | 4.42B | 4.58B | 4.85B | 4.07B | 3.91B | 3.05B |
| Cash, Cash Equivalents and Short-Term Investments | 328.00M | 577.00M | 708.00M | 495.50M | 559.10M | 587.20M |
| Total Debt | 1.84B | 1.82B | 2.00B | 1.67B | 1.59B | 1.19B |
| Total Liabilities | 3.27B | 3.20B | 3.49B | 3.03B | 3.09B | 2.39B |
| Stockholders Equity | 991.00M | 1.20B | 1.20B | 1.00B | 785.90M | 646.10M |
Cash Flow | ||||||
| Free Cash Flow | 207.70M | 288.00M | 320.20M | 77.10M | -343.90M | 162.10M |
| Operating Cash Flow | 329.90M | 433.00M | 499.70M | 233.80M | -91.80M | 319.00M |
| Investing Cash Flow | -451.50M | -154.00M | -482.00M | -199.70M | -128.90M | -137.90M |
| Financing Cash Flow | -152.70M | -409.00M | 173.00M | -83.90M | 197.70M | -17.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £243.67M | 8.03 | 32.09% | 1.47% | 2.90% | 419.40% | |
69 Neutral | £209.29M | 12.20 | 38.39% | 5.10% | -3.57% | -0.80% | |
66 Neutral | £964.95M | 23.16 | 4.21% | 6.15% | -5.74% | -75.29% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | £559.38M | 20.35 | 8.04% | 5.14% | -7.30% | -59.71% | |
58 Neutral | £285.16M | -17.98 | -8.12% | ― | -18.43% | 24.86% | |
55 Neutral | £1.07B | 38.73 | 4.10% | 3.05% | -6.95% | -52.08% |
RHI Magnesita reported a trading update for the period ending October 2025, showing an improvement in performance despite challenging market conditions. The company achieved an adjusted EBITA of €136 million over four months, with a 12.7% margin, surpassing the first half of the year. While steel volumes remained weak, the company saw growth in India and the Middle East, Africa, and Türkiye. Cost efficiency programs and plant closures in Germany contributed to margin improvements. The integration of former Resco plants is progressing well, enhancing the North American footprint. The company remains on track to meet its full-year adjusted EBITA target, with expectations of continued performance improvement into 2026.
The most recent analyst rating on (GB:RHIM) stock is a Hold with a £2189.00 price target. To see the full list of analyst forecasts on RHI Magnesita NV stock, see the GB:RHIM Stock Forecast page.
RHI Magnesita has announced the appointment of Yasmin-Sarah Solmazer as an Employee Representative Director on its Board, effective from January 1, 2026, for a four-year term. This appointment follows the stepping down of Michael Schwarz, who served in the role for eight years. The company looks forward to Solmazer’s contributions as a workforce representative, highlighting its commitment to employee representation in governance.
The most recent analyst rating on (GB:RHIM) stock is a Hold with a £2189.00 price target. To see the full list of analyst forecasts on RHI Magnesita NV stock, see the GB:RHIM Stock Forecast page.
RHI Magnesita has announced the re-appointment of Dr. Martin Kowatsch as an Employee Representative Director of the Board, effective from November 1, 2025, for a four-year term. This decision, made by the Austrian Works Council, aligns with the company’s Articles of Association and reinforces its commitment to maintaining strong employee representation at the board level, potentially impacting its governance and stakeholder relations positively.
The most recent analyst rating on (GB:RHIM) stock is a Hold with a £2189.00 price target. To see the full list of analyst forecasts on RHI Magnesita NV stock, see the GB:RHIM Stock Forecast page.
RHI Magnesita N.V. has announced its total voting rights as of September 30, 2025, with an issued share capital comprising 47,301,578 ordinary shares, excluding 2,176,127 shares held in treasury. This update is crucial for shareholders and stakeholders to determine their notification obligations under the FCA’s Disclosure Guidance and Transparency Rules, impacting how they manage their interests in the company.
The most recent analyst rating on (GB:RHIM) stock is a Hold with a £2500.00 price target. To see the full list of analyst forecasts on RHI Magnesita NV stock, see the GB:RHIM Stock Forecast page.